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It is widely accepted that percutaneous nephrostolithotorny (PCNL) is the standard of choice for the removal of large staghorn
renal calculi. Although data exists supporting a stagad ureteroscopic as an alternate treatment for stones up to 3cm in select
patients, little data exists to support a ureteroscopic approach for stones as large as 5cm. We present a case of a 68 year old female
with a 5cm staghorn renal calculus managed successfully with a staged ureteroscopic approach. A staged ureteroscopic approach
can be eﬀective in treating stones as large as 5cm.
1.Introduction
It is widely accepted that percutaneous nephrostolithotomy
(PCNL) is the standard of choice for the removal of large
staghorn renal calculi. However, there can be speciﬁc factors
in a minority of patients that make alternate techniques
such as ureteroscopy more favorable for the removal of large
staghorn calculi.
Advances in PCNL have made it the most eﬀective meth-
od to remove large staghorn calculi. Such advances include
increasing expertise of the urologists performing the pro-
cedure, the maturation of the instrumentation, and the
ability to maintain multiple tracts and perform multistaged
procedures.[1].Theseadvanceshaveledtoadecreaseinboth
operative time and postoperative complications and a stone
clearance rate of ninety-three percent. [1]. However, the
complication rate for PCNL remains fairly high at approxi-
mately eight percent. [2]. Complications from PCNL can be
devastating, including disruption of the pelvicalyceal system,
bowel perforation, and hemorrhaging requiring transfusion
or angioembolization,. [1, 3]. PCNL requires that the patient
be in the prone position. If the patient has anatomic or phys-
ical limitations that prevent prone positioning, ureteroscopy
may be a reasonable alternative to open surgery.
The evolution of ﬂexible ureteroscopes has allowed
an ease of access and excellence of visualization which
has helped make ureteroscopy a common procedure for
most urologists. The increasing use of laser technology
and electrohydraulic lithotripsy has made ureteroscopy an
eﬃcient means of treating even large renal calculi, with a
stone-free rate of about eighty-seven percent in these cases
[3, 4]. While ureteroscopy may have a slightly lower stone-
freeratethanPCNL,italsohasalowermorbidity andoverall
complication rate, at about 2 percent [3, 4]. Since staghorn
calculi are often colonized with multiple bacterial strains, all
endoscopic treatments, particularly those performed via a
retrograde approach, carry with them the risk of potentially
lethal septic shock. Nevertheless, we feel that urosepsis and
other hazards can be mitigated with a staged approach to the
procedure and the proper antimicrobial precautions.
2.Case
A 68-year-old wheelchair-bound female with a history of
cerebral palsy and severe contractures of the upper and lower
extremities presented to the emergency department with a
chief complaint of fever to 100.5F, general malaise, and
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blood cell count of 14,000. A CT scan showed a 4.8 to 5.0cm
left staghorn renal calculus with branching into the calyces
(Figure 1). The patient responded well to intravenous cef-
tazidime and ﬂuid resuscitation. A clean catheterized urine
culture grew pan-sensitive E. coli and she was discharged on
a 14-day course of ciproﬂoxacin. Prior to outpatient urologic
follow-up, her symptoms recurred in a similar manner.
Ceftriaxone was started empirically and a urine culture again
grew E. coli, this time with increasing resistance and well
as methicillin-resistant staph aureus. The patient was dis-
charged on oral cefpodoxime, again for a two-week course.
Given the failure of suppressive therapy and the presence
of recurrent, resistant, polymicrobial infections in the setting
of a large stone nidus, we felt that removal of the stone was
indicated. Stone dissolution therapy was declined in the face
of such a large stone and in the setting of rapidly recurrent
infection.Avarietyofsurgicaloptionswerethereforeconsid-
ered. Extracorporeal shockwave lithotripsy was not felt to be
an option given a stone of this size. Anatrophic nephrolitho-
tomy and open pyelolithotomy were not technically feasible
becauseofthepatient’ssevereanatomicdeformities.Particu-
larconsiderationwasgiventoPCNL,ourtreatmentofchoice
for stones of this type. Unfortunately her body habitus again
proved limiting as we were unable to place her safely into the
prone or semiprone position. As an alternative, we elected to
perform staged ureteroscopy and lithotripsy.
Intravenous vancomycin and gentamicin were started 24
hours prior to surgery. Stage I ﬂexible ureteronephroscopy
was carried out via a retrograde approach through a 36cm
access sheath. The 270 nanometer holmium laser ﬁber was
usedtobeginfragmentationofthestone.Thecompositionof
the stone was of soft to intermediate density, and we did not
feel that a larger ﬁber or electrohydraulic lithotripsy (EHL)
was required. Lithotripsy was concluded electively after one
hour and 15 minutes and a 6 French, 24-centimeter double-
J ureteral stent and 18 French urethral catheter were placed.
She would maintain a urethral catheter until the conclusion
of her treatment. Several hours postoperatively the patient
was noted to be tachycardic to 100 beats per min and with
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a temperature of 100.4. Vancomycin was continued, and
ceftrizone begun in lieu of gentamicin. She was observed
closely with prompt resolution of the tachycardia and fever,
and her symptoms were attributed to transient bacteremia
from surgical instrumentation. A urine culture obtained at
time of surgery grew Enterococcus faecalis and Pseudomonas
aeruginosa. Antibiotic coverage was switched to IV Zosyn,
which was extended and carried through a second-stage
ureteroscopy two weeks later and subsequent stent removal
two weeks after that. Total lithotripsy time for Stage II was
again roughly 1 hour and 15 minutes, and at this point
the stone was felt to be fragmented into pieces that would
spontaneously pass postoperatively. Two weeks after Stage
II, the stent was removed. One week after stent removal,
the patient developed left ﬂank pain and malaise. A CT
showed a single small obstructing distal ureteral fragment
(Figure 2). In an eﬀort to drain the infected, obstructed
kidney nephrostomy was performed. Urine culture aspirated
upon placement of the nephrostomy now showed Kleb-
siella sensitive to Ciproﬂoxacin. After quick resolution of
symptoms, a ﬁnal look ureteroscopy was performed which
conﬁrmed passage of the distal ureteral stone as well as
the vast majority of the fragments in the collecting system.
One ﬁnal small 5-6mm fragment was treated quickly and
easily using the laser. A stent was replaced. Ciproﬂoxacin
was continued throughout this procedure and through the
stent removal two weeks later. Follow-up imaging conﬁrmed
adequatetreatmentofthestone(Figure 3).Thenephrostomy
and urethral catheter were then removed. Cipro was weaned
over the next 3 weeks. At 6 months there have been no
signiﬁcant sequela and the patient’s overall mental status and
functional status are signiﬁcantly improved since removal of
the chronically infected stone.
3. Discussion
We feel that the treatment of choice for large staghorn renal
calculi remains PCNL. Nonetheless, in select patients con-
sideration must be given to a staged ureteroscopic approachCase Reports in Urology 3
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as primary treatment. Ample data supports the use of staged
u r e t e r o s c o p yf o rs t o n e su pt o2t o3c mi ns i z e .H o w e v e r ,f o r
stone diameters between 3 and 5cm, there is little data to
support such an approach. Given the 3-dimensional nat-
ure of stones, we see a drastic rise in stone volume at dia-
meters over 3cm, making the prospect of successful ureter-
oscopic approach seem daunting, especially when consid-
ering the possibility of multiple procedures. However, one
must remember that a second look ureteroscopy is often
required to clear out residual stone fragments even when
PCNLisusedasprimarytreatment.Forthisreasonwedonot
view a staged primary ureteroscopic treatment to impose a
signiﬁcantenoughanestheticriskastoprecludeitfrombeing
considered in carefully selected patients and in the appro-
priate hands. We feel that successful primary ureteroscopic
treatment is possible by using sound surgical principles and
careful pre and postoperative management techniques.
Preoperatively, careful consideration should be given to
previous culture data in order to properly select antimicro-
bial prophylaxis. We advise obtaining culturesthrough either
sterile catheterization or aspiration of the bladder or kidney
preoperatively, and also obtaining intraoperative cultures
wheneverpossible.Antibioticmanagementshouldbecarried
outwithanunderstandingthatstaghornstonescouldharbor
a variety of bacteria and antimicrobial resistance not always
accurately reported on culture.
Operatively, retrograde irrigation should be limited
during the surgical procedure. We routinely use the pulsatile
pump irrigator sparingly and advocate against continuous
high-pressure ﬂow systems to mitigate against pyelovenous
seeding of bacteria. Third, we suggest that total operative
time be limited to under 90 minutes of lithotripsy per
stage. We also suggest that careful consideration be given to
the consistency of the stone at the onset of fragmentation.
Should the stone be refractory to quick obliteration by laser,
the use of electrohydraulic lithotripsy should be considered
bythesurgeonskilledinitsuse.ForstonesrefractorytoEHL,
one should reconsider the overall feasibility of a successful
ureteroscopic procedure in general. Finally, close attention
should be paid to the patient’s intraoperative vital signs, and
the case be terminated after immediate stent placement for
any signs of urosepsis including hypotension, tachycardia,
and fever.
Postoperatively, our patient developed an obstruction
from a passing fragment after ureteral stent removal, which
necessitated placement of a nephrostomy tube. This scenario
brings to light several postoperative considerations. First, it
reinforces the notion that continued passage of fragments
should be expected after stent removal, due in part to the
sheer amount of fragments funneling at the ureteropelvic
junction. Secondly, the surgeon may underestimate the size
ofresidualfragmentsduringlithotripsybecauselargerstones
could be buried beneath the “gravel” of smaller fragments,
therefore increasing the risk of secondary obstruction. For
this reason, we feel that consideration should be given to
placement of a nephrostomy prior to Stage I as a means of
increasedrenaldrainageduringstagedureteroscopy,andalso
in an eﬀort to have readily available renal drainage should
infection or obstruction occur after stent removal. Had this
been done in our case, we may have been able to avert the
ﬁnal procedure. A last postoperative suggestion would be the
gradual weaning of antibiotic therapy for two to three weeks
as the patient recovers.
4. Conclusion
We feel that the treatment of choice for large staghorn
renal calculi remains PCNL. However, in select patients, the
literaturehasshownthatastagedureteroscopicapproachcan
beeﬀectiveinstonesaslargeas3cm.Todate,littledataexists
to support a staged ureteroscopic approach for stones up to
5cm. In our case, we have demonstrated that with careful
surgical planning and eﬃcient surgical technique, even
stones up to 5cm can be treated via a staged ureteroscopic
approach.
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